Evidence map›Paper›PMID 20045057›Full record

ArticleProtein expression and purification2010

Purification of transmembrane proteins from Saccharomyces cerevisiae for X-ray crystallography.

Kathleen M Clark, Nadia Fedoriw, Katrina Robinson, Sara M Connelly, Joan Randles, Michael G Malkowski, George T DeTitta, Mark E Dumont

Open access · greenAbstract read
In one paragraph

Article in Protein expression and purification, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Phosphoramidon inhibits the integral membrane protein zinc metalloprotease ZMPSTE24.Acta crystallographica. Section D, Structural biology · 2018
    Article
  4. Article
  5. Article
  6. Structure of the SLC4 transporter Bor1p in an inward-facing conformation.Protein science : a publication of the Protein Society · 2017
    Article
  7. Current strategies for protein production and purification enabling membrane protein structural biology.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2016
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kathleen M ClarkDepartment of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Nadia Fedoriw
Katrina Robinson
Sara M Connelly
Joan Randles
Michael G Malkowski
George T DeTitta
Mark E Dumont
University of Rochester · USHauptman-Woodward Medical Research Institute · US

Funding

TOOLS FOR HIGH THROUGHPUT STRUCTURAL BIOLOGYU54GM074899 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI DETITTA, GEORGE T · 2005 to 2010
$16.5M
NIGMS NIH HHS U54 GM074899NIGMS NIH HHS U54GM074899
6 · The paper itself

Abstract

To enhance the quantity and quality of eukaryotic transmembrane proteins (TMPs) available for structure determination by X-ray crystallography, we have optimized protocols for purification of TMPs expressed in the yeast Saccharomyces cerevisiae. We focused on a set of the highest-expressing endogenous yeast TMPs for which there are established biochemical assays. Genes encoding the target TMPs are transferred via ligation-independent cloning to a series of vectors that allow expression of reading frames fused to C-terminal His10 and ZZ (IgG-binding) domains that are separated from the reading frame by a cleavage site for rhinovirus 3C protease. Several TMP targets expressed from these vectors have been purified via affinity chromatography and gel filtration chromatography at levels and purities sufficient for ongoing crystallization trials. Initial purifications were based on expression of the genes under control of a galactose-inducible promoter, but higher cell densities and improved expression have been obtained through use of the yeast ADH2 promoter. Wide variations have been observed in the behavior of different TMP targets during purification; some can be readily purified, while others do not bind efficiently to affinity matrices, are not efficiently cleaved from the matrices, or remain tightly associated with the matrices even after cleavage of the affinity tags. The size, oligomeric state, and composition of purified protein-detergent complexes purified under different conditions were analyzed using a colorimetric assay of detergent concentrations and by analytical size-exclusion chromatography using static light scattering, refractive index, and UV absorption detection to monitor the elution profiles. Effective procedures were developed for obtaining high concentrations of purified TMPs without excessively concentrating detergents.

Indexed as

Chromatography, AffinityChromatography, GelCrystallography, X-RayEukaryotaGenetic VectorsMembrane ProteinsProtein BindingSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsX-RaysMembrane ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID20045057
PMCPMC2843815
OpenAlexW2020025084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.